Cellular Biomedicine Group Inc. , a biomedicine firm engaged in the development of new treatments for degenerative and cancerous diseases, today announced it has completed the previously announced acquisition of privately held Agreen Biotech Co. Ltd. China and its founder's U.S. patent.
http://ift.tt/1ouSNSF
http://ift.tt/1ouSNSF
No comments:
Post a Comment